WRBC
CELU icon

W.R. Berkley Corp’s Celularity CELU Stock Holding History

W.R. Berkley Corp’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-205,578
Closed -$20.9M – 449
2021
Q2 		$20.9M Buy
205,578
+1,992
+1% +$202K 2.08% 8
2021
Q1 		$20.5M Buy
203,586
+199,350
+4,706% +$20.4M 2.37% 8
2020
Q4 		$466K Sell
4,236
-62,699
-94% -$6.66M 0.08% 142
2020
Q3 		$7.03M Sell
66,935
-155,718
-70% -$16.1M 1.03% 19
2020
Q2 		$22.7M Buy
222,653
+98,050
+79% +$9.73M 3.01% 5
2020
Q1 		$12.2M Buy
124,603
+84,915
+214% +$8.4M 1.44% 15
2019
Q4 		$3.95M Hold
39,688
– – 0.72% 37
2019
Q3 		$3.95M Buy
+39,688
New +$3.89M 0.66% 44

Other funds holding CELU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

W.R. Berkley Corp's CELU Position: Q3 2021 in Review

W.R. Berkley Corp sold out of Celularity (CELU) in Q3 2021, closing a stake of 205,578 shares — an estimated $20.9M sold.

W.R. Berkley Corp first reported a position in CELU in Q3 2019 and held it in 8 quarters. The position peaked at $22.7M in Q2 2020. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

  • W.R. Berkley Corp reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
  • W.R. Berkley Corp sold 205,578 Celularity shares in Q3 2021, an estimated $20.9M.
  • W.R. Berkley Corp first reported a position in Celularity in Q3 2019 and held it in 8 quarters.
  • W.R. Berkley Corp's Celularity position peaked at $22.7M in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on W.R. Berkley Corp's 13F filing for Q3 2021, filed 15 Nov 2021.